Basic Science Program, SAIC-Frederick, Inc., Center for Cancer Research Nanobiology Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Crit Rev Biochem Mol Biol. 2013 Mar-Apr;48(2):89-97. doi: 10.3109/10409238.2012.742856. Epub 2012 Dec 13.
The ubiquitin-proteasome system (UPS) is involved in many cellular processes including protein degradation. Degradation of a protein via this system involves two successive steps: ubiquitination and degradation. Ubiquitination tags the target protein with ubiquitin-like proteins (UBLs), such as ubiquitin, small ubiquitin-like modifier (SUMO) and NEDD8, via a cascade involving three enzymes: activating enzyme E1, conjugating enzyme E2 and E3 ubiquitin ligases. The proteasomes recognize the UBL-tagged substrate proteins and degrade them. Accumulating evidence indicates that allostery is a central player in the regulation of ubiquitination, as well as deubiquitination and degradation. Here, we provide an overview of the key mechanistic roles played by allostery in all steps of these processes, and highlight allosteric drugs targeting them. Throughout the review, we emphasize the crucial mechanistic role played by linkers in allosterically controlling the UPS action by biasing the sampling of the conformational space, which facilitate the catalytic reactions of the ubiquitination and degradation. Finally, we propose that allostery may similarly play key roles in the regulation of molecular machines in the cell, and as such allosteric drugs can be expected to be increasingly exploited in therapeutic regimes.
泛素-蛋白酶体系统(UPS)参与许多细胞过程,包括蛋白质降解。通过该系统降解蛋白质涉及两个连续的步骤:泛素化和降解。泛素化通过涉及三种酶的级联反应,用泛素样蛋白(UBLs)如泛素、小分子泛素样修饰物(SUMO)和 NEDD8 对靶蛋白进行标记。蛋白酶体识别 UBL 标记的底物蛋白并将其降解。越来越多的证据表明,变构作用是泛素化以及去泛素化和降解调节的核心因素。在这里,我们概述了变构作用在这些过程的所有步骤中所起的关键机制作用,并强调了针对它们的变构药物。在整个综述中,我们强调了连接子在通过偏向构象空间采样来变构控制 UPS 作用方面所起的关键机制作用,这有利于泛素化和降解的催化反应。最后,我们提出变构作用可能同样在细胞中分子机器的调节中起关键作用,因此,预计变构药物将越来越多地被用于治疗方案。